Real-time enrollment status for this advanced hepatocellular carcinoma clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 2:15 AM UTC
| NCT Number | NCT07042919 |
| Recruiting Status | Recruiting |
| Condition | Advanced Hepatocellular Carcinoma |
| Phase | PHASE1 |
| Target Enrollment | 59 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Devalingam Mahalingam |
| Last Updated on CT.gov | June 25, 2026 (Jun 25, 2026) |
As of August 31, 2026: Clinical trial NCT07042919 is currently recruiting participants. This phase1 study for advanced hepatocellular carcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Devalingam Mahalingam. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07042919 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07042919 was last updated Jun 25, 2026 (June 25, 2026). HelloStudys verifies this status automatically.